Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Rochester Forensic Assertive Community Treatment Model in Minnesota (R-FACT)

21 mei 2026 bijgewerkt door: Steven Lamberti, University of Rochester

A Randomized Controlled Trial of the Rochester Forensic Assertive Community Treatment Model in Minnesota

This study evaluates the Rochester Forensic Assertive Community Treatment (R-FACT) model in Minnesota. R-FACT is an enhanced version of Assertive Community Treatment designed to support individuals with serious mental illness who are involved in the criminal justice system.

Participants were randomly assigned to receive either the R-FACT intervention or standard outpatient mental health services. The study examines whether R-FACT reduces criminal justice involvement, improves mental health outcomes, and enhances community functioning compared to usual care over a 24-month follow-up period.

Studie Overzicht

Gedetailleerde beschrijving

The R-FACT intervention includes a multidisciplinary team approach with reduced caseloads, enhanced supervision, and collaboration with criminal justice stakeholders.

This randomized controlled trial evaluates the effectiveness of the Rochester Forensic Assertive Community Treatment (R-FACT) model in Minnesota. R-FACT is a modified Assertive Community Treatment (ACT) model developed to address the needs of individuals with serious mental illness who are at high risk for criminal justice involvement. The model integrates best practices in community mental health (high-fidelity ACT) with best practices in community correctional supervision (Probation officers trained in Effective Practices in Community Supervision - EPICS) The study was conducted across two counties in Minnesota and enrolled adults with serious mental illness who were on probation or undergoing correctional facility release to probation. Participants were randomized to either the R-FACT intervention or standard outpatient mental health treatment.

The R-FACT intervention consists of a high-fidelity ACT team that collaborates closely with specially assigned probation officers who provide community correctional oversight of all R-FACT service recipients. The comparator group received usual care through existing outpatient mental health services along with standard probation.

Studietype

Ingrijpend

Inschrijving (Werkelijk)

40

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studie Locaties

    • New York
      • Rochester, New York, Verenigde Staten, 14642
        • University of Rochester Medical Center

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

  • Volwassen
  • Oudere volwassene

Accepteert gezonde vrijwilligers

Nee

Beschrijving

Inclusion Criteria:

  • Age 18 or older.
  • DSM-5 diagnosis of a psychotic disorder, including schizophrenia, schizoaffective disorder, bipolar disorder, or major depression with psychotic features.
  • Adequate command of English to understand study instructions.
  • Capacity to provide informed consent.
  • Under community correctional supervision or undergoing prison release planning at the time of enrollment.

Exclusion Criteria:

  • Age under 18.
  • Lack of a psychotic disorder diagnosis.
  • Inability to speak English.
  • Lack of capacity to provide informed consent.
  • Absence of community correctional supervision or of release planning.
  • Presence of legal oversight in the community from a source other than probation or community corrections. Examples include having legal oversight from a mental health court, a drug court, or from an assisted outpatient treatment (AOT) program.

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Behandeling
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Geen (open label)

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Actieve vergelijker: Standard Outpatient treatment
Participants assigned to this arm received standard outpatient mental health treatment available in the community. This includes routine psychiatric care and case management services provided through existing outpatient systems without the enhanced structure and supervision of the R-FACT model.
Routine outpatient mental health services delivered through existing community systems, including standard psychiatric care and case management without the enhanced structure or intensity of the R-FACT model.
Experimenteel: R-FACT intervention
Participants assigned to this arm received the Rochester Forensic Assertive Community Treatment (R-FACT) intervention. R-FACT is a modified Assertive Community Treatment (ACT) model designed for individuals with serious mental illness involved in or at risk of involvement in the criminal justice system. The R-FACT intervention includes a multidisciplinary treatment team with high fidelity to the ACT model (e.g. intensive staffing, assertive outreach, 24-7 availability, comprehensive services) that worked in close partnership with specially assigned probation officers over a 24-month period.
A structured, team-based model of care adapted from Assertive Community Treatment (ACT) that provides intensive, community-based psychiatric services with integrated supervision and coordination with criminal justice and social service systems. The model emphasizes reduced caseloads, frequent participant contact, continuity of care, and collaborative problem solving between mental health and criminal justice staff with an emphasis on finding therapeutic alternatives to punishment.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Mean Total Number of Days Incarcerated During the 24 Month Follow Up Period
Tijdsspanne: Randomization to 24 months after randomization
Incarceration days are measured using administrative correctional records. For each participant, the total number of days incarcerated during the 24 month follow up period is calculated from correctional database records. The outcome is reported as the mean total number of incarceration days per participant within each study arm. Higher values indicate more time spent incarcerated, and lower values indicate less time spent incarcerated.
Randomization to 24 months after randomization

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Mean Total Number of Arrests During the 24 Month Follow Up Period
Tijdsspanne: Randomization to 24 months after randomization
Arrests are measured using administrative criminal justice records. For each participant, all arrests occurring during the 24 month follow up period are counted. The outcome is reported as the mean total number of arrests per participant within each study arm. Higher values indicate more arrests.
Randomization to 24 months after randomization
Mean Total Number of Convictions During the 24 Month Follow Up Period
Tijdsspanne: Randomization to 24 months after randomization
Convictions are measured using administrative criminal justice records. For each participant, all convictions occurring during the 24 month follow up period are counted. The outcome is reported as the mean total number of convictions per participant within each study arm. Higher values indicate more convictions.
Randomization to 24 months after randomization
Mean Total Number of Community Supervision Violations During the 24 Month Follow Up Period
Tijdsspanne: Randomization to 24 months after randomization
Community supervision violations are measured using administrative criminal justice records. For each participant, all probation or parole violations occurring during the 24 month follow up period are counted. The outcome is reported as the mean total number of violations per participant within each study arm. Higher values indicate more violations.
Randomization to 24 months after randomization
Mean Total Number of Jail Stays During the 24 Month Follow Up Period
Tijdsspanne: Randomization to 24 months after randomization
Jail stays are measured using correctional administrative records. For each participant, the number of separate jail admissions occurring during the 24 month follow up period is counted. The outcome is reported as the mean total number of jail stays per participant within each study arm. Higher values indicate more jail admissions.
Randomization to 24 months after randomization

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

23 januari 2020

Primaire voltooiing (Werkelijk)

5 april 2025

Studie voltooiing (Werkelijk)

5 april 2025

Studieregistratiedata

Eerst ingediend

11 mei 2026

Eerst ingediend dat voldeed aan de QC-criteria

11 mei 2026

Eerst geplaatst (Werkelijk)

18 mei 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

26 mei 2026

Laatste update ingediend die voldeed aan QC-criteria

21 mei 2026

Laatst geverifieerd

1 mei 2026

Meer informatie

Termen gerelateerd aan deze studie

Andere studie-ID-nummers

  • STUDY00001721
  • AWD00002196 (Ander subsidie-/financieringsnummer: Arnold Ventures)

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren